Resectable Mucosal Melanoma clinical trials

Explore recruiting resectable mucosal melanoma clinical trials.

Recruiting resectable mucosal melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Mucosal Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II multicentric study: efficacy evaluation of neo-adjuvant treatment associated with maintenance therapy by anti-PD1 immunotherapy on disease-free-survival (DFS) in patients with resectable mucosal melanoma (IMMUQ)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Resectable Mucosal Melanoma trials by city

Resectable Mucosal Melanoma in Toronto Resectable Mucosal Melanoma in Vancouver Resectable Mucosal Melanoma in Montreal Resectable Mucosal Melanoma in Calgary Resectable Mucosal Melanoma in Edmonton Resectable Mucosal Melanoma in Ottawa Resectable Mucosal Melanoma in Winnipeg Resectable Mucosal Melanoma in Quebec City Resectable Mucosal Melanoma in Hamilton Resectable Mucosal Melanoma in Kitchener Resectable Mucosal Melanoma in London Resectable Mucosal Melanoma in Halifax Resectable Mucosal Melanoma in New York Resectable Mucosal Melanoma in Los Angeles Resectable Mucosal Melanoma in Chicago Resectable Mucosal Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease